Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 634 of 6351
-
New drug D-2570 aims to quiet Flare-Ups in ulcerative colitis
Disease control OngoingThis study is a multicenter, randomized, double-blind, placebo-controlled clinical trial. The target population is patients with moderately to severely active ulcerative colitis. A total of 120 subjects are planned to be included.
Phase 2 • Sponsor: InventisBio Co., Ltd • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New hope for advanced melanoma: experimental combo enters late-stage trial
Disease control Recruiting nowThe study is for patients with advanced melanoma who are eligible for standard therapy with Pembrolizumab.
Phase 2/3 • Sponsor: Eikon Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New drug cocktail targets Hard-to-Treat colorectal cancer mutation
Disease control By invitation onlyThis is an open-label, multicenter, single-arm Phase II clinical study, divided into subgroups A and B: Cohort A - To evaluate the efficacy and safety of IBI351, cetuximab β combined with FOLFIRI as first-line treatment for metastatic colorectal cancer with KRAS G12C mutations; …
Phase 2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New hope for womb cancer: drug duo aims to slow tumor growth
Disease control Recruiting nowResearchers are looking for new ways to treat people with proficient mismatch repair (pMMR) endometrial cancer (EC) that is advanced or recurrent. * EC is a type of cancer that starts in the tissues inside the uterus (womb) * pMMR indicates that certain normal proteins are prese…
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
New antibody drug aims to protect kidneys in PMN patients
Disease control Recruiting nowIn this study, researchers will learn more about the use of felzartamab in participants with primary membranous nephropathy, also known as PMN. In people with PMN, autoantibodies build up in the glomeruli of the kidney. Antibodies are proteins that help the body fight off infecti…
Phase 3 • Sponsor: Biogen • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
New drug combo aims to prevent transplant complications in blood cancer patients
Disease control Recruiting nowThe purpose of this study is to find out whether adding belumosudil to a usual approach for reducing the risk of graft-versus-host disease (GVHD) may be an effective GVHD prevention approach for people with blood cancer who have a stem cell transplant. The investigators will also…
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Which carotid fix works best right after a stroke? a Head-to-Head trial
Disease control By invitation onlyThe objective of this clinical trial is to compare immediate and long-term results of carotid endarterectomy and carotid stenting in acute period of ischemic stroke. Patients who presented with acute stage of ischemic stroke will be treated by carotid artery stenting in 50 cases …
Sponsor: Pirogov Russian National Research Medical University • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
New drug cocktail IoVeX offers hope for relapsed leukemia patients
Disease control Recruiting nowThe goal of this clinical trial is to learn if the combination of drugs Inotuzumab Ozogamicin, Venetoclax, and Dexamethasone (IoVeX) are safe to treat relapsed B-cell Acute Lymphoblastic Leukemia (B-ALL) in pediatric and adult patients. It will also learn if these drugs are well …
Phase 1 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Can a common antibiotic beat MRSA in kids? a trial puts TMP-SMX to the test
Disease control Recruiting nowThe goal of this clinical trial is to learn if trimethoprim-sulfamethoxazole (TMP-SMX) works to treat invasive infections due to methicillin-resistant Staphylococcus aureus (MRSA) in children. It will also learn about the safety of TMP-SMX in the treatment of children with invasi…
Phase 4 • Sponsor: Indiana University • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Can a painless laser on the ear silence chronic pain in seniors?
Symptom relief CompletedThe objective of the study to evaluate the effectiveness of a treatment protocol using auricular acupuncture point stimulation with laser , compared to the use of mustard seeds, for reducing chronic pain in the elderly. With this research, the researches hope to obtain results th…
Sponsor: Universidade do Vale do Paraíba • Aim: Symptom relief
Last updated Aug 13, 2026 00:00 UTC
-
Can we untangle the overlap of lung diseases? a new study aims to find out
Knowledge-focused Recruiting nowThis study focuses on both hospitalized and outpatient populations. Through a multicenter, retrospective study, it aims to comprehensively characterize:The comorbidity of interstitial lung diseases (ILD) and airway diseases;The comorbidity of ILD with other intrapulmonary disease…
Sponsor: Xiangya Hospital of Central South University • Aim: Knowledge-focused
Last updated Aug 26, 2026 00:00 UTC
-
Balloon vs. stent: new hope for tiny heart arteries?
Disease control Recruiting nowThis is a multicenter, randomized, single-blind pivotal study to evaluate the safety and efficacy of the MagicTouchTM Drug coated balloon in treatment of small vessels in patients with coronary artery disease. The objective is to establish the safety and efficacy of the Magic Tou…
Sponsor: Concept Medical Inc. • Aim: Disease control
Last updated Jun 26, 2026 15:36 UTC
-
Could a VR headset replace the Dentist's drill of dread?
Symptom relief CompletedThis study evaluated whether immersive virtual reality (VR) can help reduce pain and dental fear and improve behavioral cooperation in children undergoing restorative dental treatment. Children aged 8-12 years who required treatment of primary molars were randomly assigned to eit…
Sponsor: University of Gaziantep • Aim: Symptom relief
Last updated Aug 26, 2026 00:00 UTC
-
Peer support trial aims to ease mental health crisis for Nepal's LGBTIQA+ community
Symptom relief OngoingLesbian, Gay, Bisexual, Transgender, Intersex, Queer, Asexual, and other sexually or gender diverse (LGBTIQA+) communities in many countries face high levels of mental health problems compared to the general population. This is often due to discrimination, being excluded, abuse, …
Sponsor: Public Health and Environment Research Centre (PERC), Nepal • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC
-
New pill combo aims to cut heart failure deaths and hospital stays
Disease control Recruiting nowThis study is open to adults with chronic heart failure (HF) who have a reduced left ventricular ejection fraction (LVEF) of less than 40%. People can join the study if they have been diagnosed with chronic HF at least 3 months before they start on the study. The purpose of this …
Phase 3 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New drug duo targets hard-to-treat cancers in early trial
Disease control Recruiting nowThis trial is designed to assess the tolerability, safety, pharmacokinetic profile, and preliminary efficacy of the combination of ZGGS18 and ZG005 in patients with advanced solid tumors, including advanced cervical cancer, hepatocellular carcinoma, neuroendocrine cancer, and lun…
Phase 1/2 • Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New hope for tough blood cancers: ARD103 trial opens
Disease control Recruiting nowThis is a phase I/2, interventional, open-label, multicenter study to assess the safety and efficacy of ARD103 in patients with relapsed or refractory acute myeloid leukemia or myelodysplastic syndrome.
Phase 1/2 • Sponsor: ARCE Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New radiation method aims to boost tumor fight in sarcoma patients
Disease control Recruiting nowThis study is a multicenter, prospective, randomized controlled phase II clinical trial designed to evaluate the efficacy and safety of Spatially Fractionated Radiation Therapy (SFRT) compared to Conventional Radiation Therapy (CRT) in the treatment of soft tissue sarcoma (STS, m…
Sponsor: Shandong Cancer Hospital and Institute • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
AI spots lung cancer risk from routine chest X-Rays
Diagnosis Recruiting nowThe goal of this clinical trial is to evaluate whether an AI tool that alerts providers to patients at high 6-year risk of lung cancer based on their chest x-ray images will improve lung cancer screening CT participation. The main question it aims to answer is: Does the AI tool i…
Sponsor: Massachusetts General Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:32 UTC
-
Could a probiotic cocktail delay Parkinson's? new trial launches
Disease control Recruiting nowPreclinical human trials will be utilized to validate the research direction, followed by clinical trials to assess the impact of a cocktail formula product containing the optimal probiotic Y7 combined metabolites on motor, cognitive, and non-motor functions in early Parkinson's …
Sponsor: Taipei Medical University • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC